智飞生物 reported revenue of ¥4.02B for the period ended 2026-06-30, -18.4% year on year. Net income was ¥-0.82B, a -20.4% net margin on a 18.1% gross margin. The largest revenue line is 代理产品 at 89% of the total. Free cash flow for the period was ¥1.60B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥4.02B | -18.4% |
| Gross profit | ¥0.73B | — |
| Operating income | ¥-0.97B | — |
| Net income | ¥-0.82B | — |
| Gross margin | 18.1% | Net margin -20.4% |
| Revenue Q/Q | -12.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 代理产品 | ¥3.59B | 89.3% |
| 自主产品 | ¥0.38B | 9.5% |
| 其他 | ¥0.05B | 1.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.30B | 81.9% |
| R&D | ¥0.43B | 10.6% |
| SG&A | ¥0.93B | 23.1% |
| Tax & other | ¥-0.15B | -3.7% |
| Item | Amount |
|---|---|
| Total assets | ¥27.82B |
| Total liabilities | ¥12.53B |
| Shareholders' equity | ¥15.29B |
| Equity / assets | 54.9% |
| Operating cash flow | ¥1.70B |
| Capital expenditure | ¥0.10B |
| Free cash flow | ¥1.60B |
| Cash conversion (OCF / net income) | -241% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
汇川技术 ・ 光线传媒 ・ 阳光电源 ・ 中际旭创 ・ 晶盛机电 ・ 天孚通信 ・ 三环集团 ・ 芒果超媒 ・ 昆仑万维 ・ 蓝思科技 ・ 润泽科技 ・ 先导智能
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies